Compare LNTH & PPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNTH | PPC |
|---|---|---|
| Founded | 1956 | 1946 |
| Country | United States | United States |
| Employees | N/A | 52100 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Meat/Poultry/Fish |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.2B |
| IPO Year | 2014 | 1997 |
| Metric | LNTH | PPC |
|---|---|---|
| Price | $105.79 | $28.20 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $87.00 | $41.33 |
| AVG Volume (30 Days) | 877.3K | ★ 1.5M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 6.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.80 | 0.43 |
| Revenue | $343,374,000.00 | ★ $18,497,553,000.00 |
| Revenue This Year | N/A | $2.46 |
| Revenue Next Year | $14.19 | $1.83 |
| P/E Ratio | ★ $58.87 | $63.77 |
| Revenue Growth | ★ 3.62 | 3.46 |
| 52 Week Low | $47.27 | $26.50 |
| 52 Week High | $111.86 | $50.56 |
| Indicator | LNTH | PPC |
|---|---|---|
| Relative Strength Index (RSI) | 54.07 | 47.62 |
| Support Level | $93.33 | $27.00 |
| Resistance Level | $111.86 | $29.25 |
| Average True Range (ATR) | 3.76 | 1.00 |
| MACD | -0.77 | 0.05 |
| Stochastic Oscillator | 49.67 | 53.54 |
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed JBS's offer undervalued Pilgrim's Pride.